{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:28:42Z","timestamp":1786991322425,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaip.2021.06.058","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T18:25:35Z","timestamp":1626719135000},"page":"4069-4074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ciclesonide Impacts Clinicopathological Features of Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8054-2963","authenticated-orcid":false,"given":"Mason","family":"Nistel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn T.","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calies","family":"Menard-Katcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.06.058_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.058_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","article-title":"Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children","volume":"6","author":"Schaefer","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.058_bib3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.058_bib4","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.019","article-title":"Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis","volume":"147","author":"Butz","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.058_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.058_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0000000000000848","article-title":"Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis","volume":"61","author":"Harel","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.06.058_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-016-0154-9","article-title":"Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis","volume":"12","author":"Ahmet","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.058_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/ped.2017.0779","article-title":"Adrenal insufficiency in pediatric eosinophilic esophagitis patients treated with swallowed topical steroids","volume":"30","author":"Hsu","year":"2017","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.jaip.2021.06.058_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2015.11.026","article-title":"Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis","volume":"170","author":"Golekoh","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2021.06.058_bib10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0091270009354994","article-title":"Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma","volume":"50","author":"Xu","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.06.058_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pupt.2005.02.012","article-title":"Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide","volume":"18","author":"Nave","year":"2005","journal-title":"Pulmon Pharmacol Therapeut"},{"key":"10.1016\/j.jaip.2021.06.058_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2007.01.031","article-title":"The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue","volume":"73","author":"Mutch","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaip.2021.06.058_bib13","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.rmed.2007.03.001","article-title":"A\u00a0randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma","volume":"101","author":"Boulet","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.06.058_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jaci.2012.03.007","article-title":"Successful treatment of eosinophilic esophagitis with ciclesonide","volume":"129","author":"Schroeder","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.058_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00003088-200443070-00004","article-title":"Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects","volume":"43","author":"Nave","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaip.2021.06.058_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0091270002250998","article-title":"Population pharmacokinetics and pharmacodynamics of ciclesonide","volume":"43","author":"Rohatagi","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.06.058_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0091270004271094","article-title":"Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma","volume":"45","author":"Richter","year":"2005","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.06.058_bib18","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.06.058_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2021.06.058_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cgh.2017.12.019","article-title":"Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children","volume":"16","author":"Wechsler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.058_bib21","series-title":"Alvesco Inhalation Aerosol Prescribing Information","year":"2019"},{"key":"10.1016\/j.jaip.2021.06.058_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2012.06.053","article-title":"Topical inhaled ciclesonide for treatment of eosinophilic esophagitis","volume":"130","author":"Lee","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.058_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.06.058_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.06.058_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A\u00a0phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2021.06.058_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.03.047","article-title":"Medication adherence aligns with age and a behavioral checklist but not symptoms or quality of life for patients with eosinophilic esophagitis","volume":"235","author":"Mehta","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaip.2021.06.058_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpeds.2005.10.028","article-title":"Once-daily ciclesonide in children: efficacy and safety in asthma","volume":"148","author":"Gelfand","year":"2006","journal-title":"J\u00a0Pediatr"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821007923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821007923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:31:55Z","timestamp":1761975115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821007923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213219821007923"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.058","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ciclesonide Impacts Clinicopathological Features of Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.06.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}